Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape JAMA Psychiatry March 29, 2023 Sarah Mcnamee, Neşe Devenot, Meaghan Buisson 167 citations This Viewpoint discusses serious adverse events linked to interactions between therapists and patients in trials of psychedelic-assisted therapy. DOI: 10.1001/jamapsychiatry.2023.0099 (opens in new tab)